NIPS
ACMG Strongly Recommends NIPS for Common Trisomies for All Pregnancies
The new guidelines, based on a recent evidence review, also recommend offering NIPS for detecting fetal sex chromosome aneuploidies for singleton pregnancies.
BillionToOne Secures $83.5M in Private Funding, Loan Facility; Shows Clinical Performance of NIPT
Premium
In a recent study, pregnancy outcomes correlated with the Unity test's fetal risk estimates for recessive conditions, and the company is now conducting further validation studies.
Genome-Wide Noninvasive Prenatal Genetic Testing Uncovers Additional Findings Beyond Common Trisomies
The results from the Dutch TRIDENT-2 study found that many of those findings have a clinical impact.
ACMG Review Finds NIPS Accurately Detects Common Trisomies in General-Risk Pregnancies
The review is going to inform upcoming clinical practice guidelines for noninvasive prenatal screening from the American College of Medical Genetics and Genomics.
BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche
The business will complement BioReference's specialty health division GenPath, which offers a noninvasive prenatal screening test.
Feb 25, 2021
Natera Revenues Grow 35 Percent in Q4
Oct 26, 2020
Yourgene H1 Revenues Up 5 Percent
Sep 11, 2020
Natera Prices $250M Public Stock Offering
May 6, 2020
Natera Q1 Revenues Grow 41 Percent
Apr 20, 2020
Yourgene Health Fiscal 2020 Revenues Up 86 Percent
Apr 14, 2020
Natera Prices $250M Senior Notes Offering
Nov 8, 2019